BIOMARIN PHARMACEUTICAL

biomarin-pharmaceutical-logo

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises three approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany.
#People #Financial #Event #Website #More

BIOMARIN PHARMACEUTICAL

Social Links:

facebook

Facebook

linkedin

Linkedin

x

X

instagram

Instagram

Industry:
Biotechnology Developer Platform

Founded:
1997-03-01

Address:
San Rafael, California, United States

Country:
United States

Website Url:
http://www.biomarin.com

Total Employee:
1001+

Status:
Active

Contact:
415-506-6700

Email Addresses:
[email protected]

Total Funding:
585.8 M USD

Technology used in webpage:
IPhone / Mobile Compatible SPF SSL By Default Domain Not Resolving Mobile Non Scaleable Content Nginx Amazon IPv6 JsDelivr Microsoft Azure DNS



Current Advisors List

william-young_image

William Young Member of the Board of Directors @ BioMarin Pharmaceutical
Board_member

kenneth-m-bate_image

Kenneth M. Bate Board of Directors @ BioMarin Pharmaceutical
Board_member

david-pyott_image

David Pyott Member of the Board of Directors @ BioMarin Pharmaceutical
Board_member

Current Employees Featured

chieze-ibeneche-nnewihe_image

Chieze Ibeneche-Nnewihe
Chieze Ibeneche-Nnewihe Director, Business Development and Corporate Strategy @ BioMarin Pharmaceutical
Director, Business Development and Corporate Strategy
2020-08-01

not_available_image

Geoff Nichol
Geoff Nichol CMO & SVP, Global Clinical Development @ BioMarin Pharmaceutical
CMO & SVP, Global Clinical Development
2016-11-01

chris-houlder_image

Chris Houlder
Chris Houlder Head of Global Cybersecurity @ BioMarin Pharmaceutical
Head of Global Cybersecurity
2020-09-01

kevin-eggan_image

Kevin Eggan
Kevin Eggan Head of Research and Early Development @ BioMarin Pharmaceutical
Head of Research and Early Development
2020-10-01

not_available_image

Victoria Sluzky
Victoria Sluzky Senior VP, Global Quality and Development @ BioMarin Pharmaceutical
Senior VP, Global Quality and Development
2003-02-01

diane-white_image

Diane White
Diane White Exec. Director, Head of Global Project Management @ BioMarin Pharmaceutical
Exec. Director, Head of Global Project Management
2019-10-01

jean-jacques-bienaime_image

Jean-Jacques Bienaime
Jean-Jacques Bienaime Chairman of the Board & Chief Executive Officer @ BioMarin Pharmaceutical
Chairman of the Board & Chief Executive Officer
2005-05-01

brinda-balakrishnan_image

Brinda Balakrishnan
Brinda Balakrishnan Group Vice President, Corporate and Business Development @ BioMarin Pharmaceutical
Group Vice President, Corporate and Business Development
2015-01-01

nicole-zilveti_image

Nicole Zilveti
Nicole Zilveti Development Sciences Operations Sr. Admin @ BioMarin Pharmaceutical
Development Sciences Operations Sr. Admin
2016-06-01

paul-stanley_image

Paul Stanley
Paul Stanley Senior Director of Facilities @ BioMarin Pharmaceutical
Senior Director of Facilities
2013-10-01

Founder


not_available_image

Christopher Starr

not_available_image

Grant Denison

Stock Details


Company's stock symbol is NASDAQ:BMRN

Acquisitions List

Date Company Article Price
2014-11-24 Prosensa Prosensa acquired by BioMarin Pharmaceutical 840 M USD
2013-01-07 Zacharon Pharmaceuticals Zacharon Pharmaceuticals acquired by BioMarin Pharmaceutical N/A
2010-08-17 Zystor Zystor acquired by BioMarin Pharmaceutical 115 M USD
2010-02-10 LEAD Therapeutics LEAD Therapeutics acquired by BioMarin Pharmaceutical 97 M USD
2009-10-26 Huxley Pharmaceuticals Huxley Pharmaceuticals acquired by BioMarin Pharmaceutical N/A
2002-02-07 Glyko Biomedical Glyko Biomedical acquired by BioMarin Pharmaceutical N/A

Newest Events participated

14th-annual-international-pediatric-orthopaedic-symposium_event_image Participated in 14th Annual International Pediatric Orthopaedic Symposium on 2017-11-28 as sponsor

abilities-expo-houston-2015_event_image Participated in Abilities Expo Houston 2015 on 2015-07-31 as exhibitor

Key Employee Changes

Date New article
2021-10-04 BioMarin snags Vertex VP as CMO a month after clinical snafu in gene therapy trial

Official Site Inspections

http://www.biomarin.com Semrush global rank: 1.68 M Semrush visits lastest month: 14.5 K

  • Host name: 13.107.253.41
  • IP address: 13.107.253.41
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "BioMarin Pharmaceutical" on Search Engine